oudly supported the IITs as part of its longstanding commitment to understanding patients’ evolving needs and supporting to deliver the best solutions for optimal patient outcomes. This approach to evidence generation, informed by realworld needs, and enabled by the broadest Injectable Aesthetics portfolio in the industry, is designed to support advancements at every stage of the patient journey.

Menopause: Dualsequence study shows meaningful skin quality improvements and growing patient satisfaction with both Restylane Skinboosters and Sculptra

New interim results from a ninemonth clinical sequencing IIT of women in menopause conducted by Dr. Andreas Nikolis, both on the face and the décolletage, demonstrated that the combination of Restylane Skinboosters and Sculptra drove progressive and meaningful improvements in skin quality, with the most pronounced gains in hydration seen when using Restylane Skinboosters first.1Hydration is a critical factor in
=*=*=*=*=*=
当前为第3/13页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页